drugset / Trial / NCT04135508
A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
Timeline
- Start
- 2016-12-13
- Primary completion
- 2018-03-22
- Completion
- 2018-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Subject | BAT1406 | Unknown | 40 mg | Subcutaneous |